<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">36526981</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>06</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">1542-6416</ISSN><JournalIssue CitedMedium="Print"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>17</Day></PubDate></JournalIssue><Title>Clinical proteomics</Title><ISOAbbreviation>Clin Proteomics</ISOAbbreviation></Journal><ArticleTitle>Proteomic profiling of end-stage COVID-19 lung biopsies.</ArticleTitle><Pagination><StartPage>46</StartPage><MedlinePgn>46</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">46</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12014-022-09386-6</ELocationID><Abstract><AbstractText>The outbreak of a novel coronavirus (SARS-CoV-2) in 2019 led to a worldwide pandemic, which remains an&#xa0;integral part of our lives to this day. Coronavirus disease (COVID-19) is a flu like condition, often accompanied by high fever and respiratory distress. In some cases, conjointly with other co-morbidities, COVID-19 can become severe, leading to lung arrest and even death. Although well-known from a clinical standpoint, the mechanistic understanding of lethal COVID-19 is still rudimentary. Studying the pathology and changes on a molecular level associated with the resulting COVID-19 disease is impeded by the highly infectious nature of the virus and the concomitant sampling challenges. We were able to procure COVID-19 post-mortem lung tissue specimens by our collaboration with the BSL-3 laboratory of the Biobanking and BioMolecular resources Research Infrastructure Austria which we subjected to state-of-the-art quantitative proteomic analysis to better understand the pulmonary manifestations of lethal COVID-19. Lung tissue samples from age-matched non-COVID-19 patients who died within the same period were used as controls. Samples were subjected to parallel accumulation-serial fragmentation combined with data-independent acquisition (diaPASEF) on a timsTOF Pro and obtained raw data was processed using DIA-NN software. Here we report that terminal COVID-19 patients display an increase in inflammation, acute immune response and blood clot formation (with concomitant triggering of fibrinolysis). Furthermore, we describe that COVID-19 diseased lungs undergo severe extracellular matrix restructuring, which was corroborated on the histopathological level. However, although undergoing an injury, diseased lungs seem to have impaired proliferative and tissue repair signalling, with several key kinase-mediated signalling pathways being less active. This might provide a mechanistic link to post-acute sequelae of COVID-19 (PASC; "Long COVID"). Overall, we emphasize the importance of histopathological patient stratification when interpreting molecular COVID-19 data.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Gindlhuber</LastName><ForeName>Juergen</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Tomin</LastName><ForeName>Tamara</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Institute of Chemical Technologies and Analytics, Faculty of Technical Chemistry, Technische Universit&#xe4;t Wien, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wiesenhofer</LastName><ForeName>Florian</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Christian Doppler Laboratory for Molecular Stress Research in Peritoneal Dialysis, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Nephrology and Gastroenterology, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zacharias</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liesinger</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Demichev</LastName><ForeName>Vadim</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Institute of Biochemistry, Charit&#xe9;-Universit&#xe4;tsmedizin Berlin, Berlin, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kratochwill</LastName><ForeName>Klaus</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Christian Doppler Laboratory for Molecular Stress Research in Peritoneal Dialysis, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Pediatric Nephrology and Gastroenterology, Department of Pediatrics and Adolescent Medicine, Comprehensive Center for Pediatrics, Medical University of Vienna, Vienna, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gorkiewicz</LastName><ForeName>Gregor</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schittmayer</LastName><ForeName>Matthias</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Institute of Chemical Technologies and Analytics, Faculty of Technical Chemistry, Technische Universit&#xe4;t Wien, Vienna, Austria. matthias.schittmayer@tuwien.ac.at.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Birner-Gruenberger</LastName><ForeName>Ruth</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Diagnostic and Research Institute of Pathology, Medical University of Graz, Graz, Austria. ruth.birner-gruenberger@tuwien.ac.at.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Chemical Technologies and Analytics, Faculty of Technical Chemistry, Technische Universit&#xe4;t Wien, Vienna, Austria. ruth.birner-gruenberger@tuwien.ac.at.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>W1226</GrantID><Agency>Austrian Science Fund</Agency><Country/></Grant><Grant><GrantID>F73</GrantID><Agency>Austrian Science Fund</Agency><Country/></Grant><Grant><GrantID>161L0221</GrantID><Agency>German Ministry of Education and Research (BMBF)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Proteomics</MedlineTA><NlmUniqueID>101184586</NlmUniqueID><ISSNLinking>1542-6416</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Extracellular matrix</Keyword><Keyword MajorTopicYN="N">Lung</Keyword><Keyword MajorTopicYN="N">Proteomics</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Signaling</Keyword></KeywordList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>12</Month><Day>16</Day><Hour>23</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>12</Month><Day>17</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36526981</ArticleId><ArticleId IdType="pmc">PMC9758034</ArticleId><ArticleId IdType="doi">10.1186/s12014-022-09386-6</ArticleId><ArticleId IdType="pii">10.1186/s12014-022-09386-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O, et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367:1260&#x2013;1263. doi: 10.1126/science.abb2507.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abb2507</ArticleId><ArticleId IdType="pmc">PMC7164637</ArticleId><ArticleId IdType="pubmed">32075877</ArticleId></ArticleIdList></Reference><Reference><Citation>Seyed Hosseini E, Riahi Kashani N, Nikzad H, Azadbakht J, Hassani Bafrani H, Haddad KH. The novel coronavirus Disease-2019 (COVID-19): Mechanism of action, detection and recent therapeutic strategies. Virology. 2020;551:1&#x2013;9. doi: 10.1016/j.virol.2020.08.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2020.08.011</ArticleId><ArticleId IdType="pmc">PMC7513802</ArticleId><ArticleId IdType="pubmed">33010669</ArticleId></ArticleIdList></Reference><Reference><Citation>Stawicki SP, Jeanmonod R, Miller AC, Paladino L, Gaieski DF, Yaffee AQ, et al. The 2019&#x2013;2020 novel coronavirus (Severe Acute Respiratory Syndrome Coronavirus 2) pandemic: a joint American College of Academic International Medicine-World Academic Council of Emergency Medicine Multidisciplinary COVID-19 Working Group Consensus Paper. J Glob Infect Dis. 2020;12:47&#x2013;93. doi: 10.4103/jgid.jgid_86_20.</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/jgid.jgid_86_20</ArticleId><ArticleId IdType="pmc">PMC7384689</ArticleId><ArticleId IdType="pubmed">32773996</ArticleId></ArticleIdList></Reference><Reference><Citation>Bharat A, Querrey M, Markov NS, Kim S, Kurihara C, Garza-Castillon R, et al. Lung transplantation for patients with severe COVID-19. Sci Transl Med. 2020;12:eabe4282. doi: 10.1126/scitranslmed.abe4282.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abe4282</ArticleId><ArticleId IdType="pmc">PMC8050952</ArticleId><ArticleId IdType="pubmed">33257409</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell WB. Thromboinflammation in COVID-19 acute lung injury. Paediatr Respir Rev. 2020;35:20&#x2013;24. doi: 10.1016/j.prrv.2020.06.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.prrv.2020.06.004</ArticleId><ArticleId IdType="pmc">PMC7289106</ArticleId><ArticleId IdType="pubmed">32653469</ArticleId></ArticleIdList></Reference><Reference><Citation>Lax SF, Skok K, Zechner P, Kessler HH, Kaufmann N, Koelblinger C, et al. Pulmonary arterial thrombosis in COVID-19 with fatal outcome: results from a prospective, single-center. Clinicopathol Case Series Ann Intern Med. 2020;173:350&#x2013;361. doi: 10.7326/M20-2566.</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/M20-2566</ArticleId><ArticleId IdType="pmc">PMC7249507</ArticleId><ArticleId IdType="pubmed">32422076</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese F, Pezzuto F, Fortarezza F, Hofman P, Kern I, Panizo A, et al. Pulmonary pathology and COVID-19: lessons from autopsy. The experience of European Pulmonary Pathologists. Virchows Arch. 2020;477:359&#x2013;372. doi: 10.1007/s00428-020-02886-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00428-020-02886-6</ArticleId><ArticleId IdType="pmc">PMC7343579</ArticleId><ArticleId IdType="pubmed">32642842</ArticleId></ArticleIdList></Reference><Reference><Citation>Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L, et al. Dexamethasone in Hospitalized Patients with Covid-19. N Engl J Med. 2021;384:693&#x2013;704. doi: 10.1056/NEJMoa2021436.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2021436</ArticleId><ArticleId IdType="pmc">PMC7383595</ArticleId><ArticleId IdType="pubmed">32678530</ArticleId></ArticleIdList></Reference><Reference><Citation>Zacharias M, Kashofer K, Wurm P, Regitnig P, Sch&#xfc;tte M, Neger M, et al. Host and microbiome features of secondary infections in lethal covid-19. IScience. 2022;25(9):104926. doi: 10.1016/j.isci.2022.104926.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.isci.2022.104926</ArticleId><ArticleId IdType="pmc">PMC9374491</ArticleId><ArticleId IdType="pubmed">35992303</ArticleId></ArticleIdList></Reference><Reference><Citation>World Medical Association Declaration of Helsinki ethical principles for medical research involving human subjects. JAMA. 2013;310:2191&#x2013;2194. doi: 10.1001/jama.2013.281053.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2013.281053</ArticleId><ArticleId IdType="pubmed">24141714</ArticleId></ArticleIdList></Reference><Reference><Citation>Rappsilber J, Mann M, Ishihama Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nat Protoc. 2007;2:1896&#x2013;1906. doi: 10.1038/nprot.2007.261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2007.261</ArticleId><ArticleId IdType="pubmed">17703201</ArticleId></ArticleIdList></Reference><Reference><Citation>Meier F, Brunner A-D, Frank M, Ha A, Bludau I, Voytik E, et al. diaPASEF: parallel accumulation-serial fragmentation combined with data-independent acquisition. Nat Methods. 2020;17:1229&#x2013;1236. doi: 10.1038/s41592-020-00998-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-020-00998-0</ArticleId><ArticleId IdType="pubmed">33257825</ArticleId></ArticleIdList></Reference><Reference><Citation>Demichev V, Messner CB, Vernardis SI, Lilley KS, Ralser M. DIA-NN: neural networks and interference correction enable deep proteome coverage in high throughput. Nat Methods. 2020;17:41&#x2013;44. doi: 10.1038/s41592-019-0638-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-019-0638-x</ArticleId><ArticleId IdType="pmc">PMC6949130</ArticleId><ArticleId IdType="pubmed">31768060</ArticleId></ArticleIdList></Reference><Reference><Citation>Demichev V, Yu F, Teo GC, Szyrwiel L, Rosenberger GA, Decker J, et al. High sensitivity dia-PASEF proteomics with DIA-NN and FragPipe. Biorxiv. 2021 doi: 10.1101/2021.03.08.434385.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.03.08.434385</ArticleId><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Perez-Riverol Y, Csordas A, Bai J, Bernal-Llinares M, Hewapathirana S, Kundu DJ, et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 2019;47:D442&#x2013;D450. doi: 10.1093/nar/gky1106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gky1106</ArticleId><ArticleId IdType="pmc">PMC6323896</ArticleId><ArticleId IdType="pubmed">30395289</ArticleId></ArticleIdList></Reference><Reference><Citation>Phipson B, Lee S, Majewski IJ, Alexander WS, Smyth GK. Robust hyperparameter estimation protects against hypervariable genes and improves power to detect differential expression. Ann Appl Stat. 2016;10:946&#x2013;963. doi: 10.1214/16-AOAS920.</Citation><ArticleIdList><ArticleId IdType="doi">10.1214/16-AOAS920</ArticleId><ArticleId IdType="pmc">PMC5373812</ArticleId><ArticleId IdType="pubmed">28367255</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13:731&#x2013;740. doi: 10.1038/nmeth.3901.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3901</ArticleId><ArticleId IdType="pubmed">27348712</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon SM. Proteomic Diversity in HDL. In: The HDL Handbook: Elsevier; 2014. p. 293&#x2013;322. 10.1016/B978-0-12-407867-3.00012-3.</Citation></Reference><Reference><Citation>Hochepied T, Berger FG, Baumann H, Libert C. &#x3b1;1-Acid glycoprotein: an acute phase protein with inflammatory and immunomodulating properties. Cytokine Growth Factor Rev. 2003;14:25&#x2013;34. doi: 10.1016/s1359-6101(02)00054-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s1359-6101(02)00054-0</ArticleId><ArticleId IdType="pubmed">12485617</ArticleId></ArticleIdList></Reference><Reference><Citation>Speeckaert MM, Delanghe JR. The potential significance of vitamin D binding protein polymorphism in COVID-19. Int J Infect Dis. 2021;109:90. doi: 10.1016/j.ijid.2021.06.044.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2021.06.044</ArticleId><ArticleId IdType="pmc">PMC8223003</ArticleId><ArticleId IdType="pubmed">34174433</ArticleId></ArticleIdList></Reference><Reference><Citation>Delanghe JR, Speeckaert R, Speeckaert MM. Behind the scenes of vitamin D binding protein: more than vitamin D binding. Best Pract Res Clin Endocrinol Metab. 2015;29:773&#x2013;786. doi: 10.1016/j.beem.2015.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.beem.2015.06.006</ArticleId><ArticleId IdType="pubmed">26522461</ArticleId></ArticleIdList></Reference><Reference><Citation>Doello K. A new pentachrome method for the simultaneous staining of collagen and sulfated mucopolysaccharides. Yale J Biol Med. 2014;87:341&#x2013;347.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4144288</ArticleId><ArticleId IdType="pubmed">25191149</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen Z, Zhang Y, Lin Z, Shi K, Jiu Y. Cytoskeleton-a crucial key in host cell for coronavirus infection. J Mol Cell Biol. 2020;12:968&#x2013;979. doi: 10.1093/jmcb/mjaa042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jmcb/mjaa042</ArticleId><ArticleId IdType="pmc">PMC7454755</ArticleId><ArticleId IdType="pubmed">32717049</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Agnillo F, Walters K-A, Xiao Y, Sheng Z-M, Scherler K, Park J, et al. Lung epithelial and endothelial damage, loss of tissue repair, inhibition of fibrinolysis, and cellular senescence in fatal COVID-19. Sci Transl Med. 2021;13:eabj7790. doi: 10.1126/scitranslmed.abj7790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abj7790</ArticleId><ArticleId IdType="pmc">PMC11000440</ArticleId><ArticleId IdType="pubmed">34648357</ArticleId></ArticleIdList></Reference><Reference><Citation>McDonald LT. Healing after COVID-19: are survivors at risk for pulmonary fibrosis? Am J Physiol Lung Cell Mol Physiol. 2021;320:L257&#x2013;L265. doi: 10.1152/ajplung.00238.2020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1152/ajplung.00238.2020</ArticleId><ArticleId IdType="pmc">PMC7900916</ArticleId><ArticleId IdType="pubmed">33355522</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Fang Y, Noble PW, Que J, Jiang D. Disruption of respiratory epithelial basement membrane in COVID-19 patients. Mol Biomed. 2021;2:8. doi: 10.1186/s43556-021-00031-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s43556-021-00031-6</ArticleId><ArticleId IdType="pmc">PMC7979449</ArticleId><ArticleId IdType="pubmed">34766002</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanderbeke L, van Mol P, van Herck Y, de Smet F, Humblet-Baron S, Martinod K, et al. Monocyte-driven atypical cytokine storm and aberrant neutrophil activation as key mediators of COVID-19 disease severity. Nat Commun. 2021;12:4117. doi: 10.1038/s41467-021-24360-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-24360-w</ArticleId><ArticleId IdType="pmc">PMC8257697</ArticleId><ArticleId IdType="pubmed">34226537</ArticleId></ArticleIdList></Reference><Reference><Citation>Baumann H. STAT activation in the acute phase response. In: Sehgal PB, Levy DE, Hirano T, editors. Signal transducers and activators of transcription (STATs) Dordrecht: Springer, Netherlands; 2003. pp. 465&#x2013;491.</Citation></Reference><Reference><Citation>Chen L, Guo D. The functions of tumor suppressor PTEN in innate and adaptive immunity. Cell Mol Immunol. 2017;14:581&#x2013;589. doi: 10.1038/cmi.2017.30.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cmi.2017.30</ArticleId><ArticleId IdType="pmc">PMC5520418</ArticleId><ArticleId IdType="pubmed">28603282</ArticleId></ArticleIdList></Reference><Reference><Citation>Getahun A, Wemlinger SM, Rudra P, Santiago ML, van Dyk LF, Cambier JC. Impaired B cell function during viral infections due to PTEN-mediated inhibition of the PI3K pathway. J Exp Med. 2017;214:931&#x2013;941. doi: 10.1084/jem.20160972.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20160972</ArticleId><ArticleId IdType="pmc">PMC5379973</ArticleId><ArticleId IdType="pubmed">28341640</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouhaddou M, Memon D, Meyer B, White KM, Rezelj VV, Correa Marrero M, et al. The Global phosphorylation landscape of SARS-CoV-2 infection. Cell. 2020;182:685&#x2013;712.e19. doi: 10.1016/j.cell.2020.06.034.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.06.034</ArticleId><ArticleId IdType="pmc">PMC7321036</ArticleId><ArticleId IdType="pubmed">32645325</ArticleId></ArticleIdList></Reference><Reference><Citation>Jones SA, Hunter CA. Is IL-6 a key cytokine target for therapy in COVID-19? Nat Rev Immunol. 2021;21:337&#x2013;339. doi: 10.1038/s41577-021-00553-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00553-8</ArticleId><ArticleId IdType="pmc">PMC8043092</ArticleId><ArticleId IdType="pubmed">33850327</ArticleId></ArticleIdList></Reference><Reference><Citation>Hussman JP. Cellular and molecular pathways of COVID-19 and potential points of therapeutic intervention. Front Pharmacol. 2020;11:1169. doi: 10.3389/fphar.2020.01169.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2020.01169</ArticleId><ArticleId IdType="pmc">PMC7406916</ArticleId><ArticleId IdType="pubmed">32848776</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaiser R, Leunig A, Pekayvaz K, Popp O, Joppich M, Polewka V, et al. Self-sustaining IL-8 loops drive a prothrombotic neutrophil phenotype in severe COVID-19. JCI Insight. 2021;6:e150862. doi: 10.1172/jci.insight.150862.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/jci.insight.150862</ArticleId><ArticleId IdType="pmc">PMC8492337</ArticleId><ArticleId IdType="pubmed">34403366</ArticleId></ArticleIdList></Reference><Reference><Citation>Castro-Caldas M, Mendes AF, Carvalho AP, Duarte CB, Lopes MC. Dexamethasone prevents interleukin-1beta-induced nuclear factor-kappaB activation by upregulating IkappaB-alpha synthesis, in lymphoblastic cells. Mediators Inflamm. 2003;12:37&#x2013;46. doi: 10.1080/0962935031000096953.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/0962935031000096953</ArticleId><ArticleId IdType="pmc">PMC1781587</ArticleId><ArticleId IdType="pubmed">12745547</ArticleId></ArticleIdList></Reference><Reference><Citation>Jee Y-K, Gilmour J, Kelly A, Bowen H, Richards D, Soh C, et al. Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment. J Biol Chem. 2005;280:23243&#x2013;23250. doi: 10.1074/jbc.M503659200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M503659200</ArticleId><ArticleId IdType="pubmed">15826950</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmoldt A, Benthe HF, Haberland G. Digitoxin metabolism by rat liver microsomes. Biochem Pharmacol. 1975;24:1639&#x2013;1641. doi: 10.1016/0006-2952(75)90094-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-2952(75)90094-5</ArticleId><ArticleId IdType="pubmed">10</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni W, Yang X, Yang D, Bao J, Li R, Xiao Y, et al. Role of angiotensin-converting enzyme 2 (ACE2) in COVID-19. Crit Care. 2020;24:422. doi: 10.1186/s13054-020-03120-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-03120-0</ArticleId><ArticleId IdType="pmc">PMC7356137</ArticleId><ArticleId IdType="pubmed">32660650</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu M, Chen Y, Xia H, Wang C, Tan CY, Cai X, et al. Transcriptional and proteomic insights into the host response in fatal COVID-19 cases. Proc Natl Acad Sci U S A. 2020;117:28336&#x2013;28343. doi: 10.1073/pnas.2018030117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2018030117</ArticleId><ArticleId IdType="pmc">PMC7668053</ArticleId><ArticleId IdType="pubmed">33082228</ArticleId></ArticleIdList></Reference><Reference><Citation>Arrossi AV, Farver C. The pulmonary pathology of COVID-19. Cleve Clin J Med. 2020 doi: 10.3949/ccjm.87a.ccc063.</Citation><ArticleIdList><ArticleId IdType="doi">10.3949/ccjm.87a.ccc063</ArticleId><ArticleId IdType="pubmed">32967859</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes KT, Beasley MB. Pulmonary manifestations of acute lung injury: more than just diffuse alveolar damage. Arch Pathol Lab Med. 2017;141:916&#x2013;922. doi: 10.5858/arpa.2016-0342-RA.</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/arpa.2016-0342-RA</ArticleId><ArticleId IdType="pubmed">27652982</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito JT, Louren&#xe7;o JD, Righetti RF, Tib&#xe9;rio IF, Prado CM, Lopes FD. Extracellular matrix component remodeling in respiratory diseases: what has been found in clinical and experimental studies? Cells. 2019;8:342. doi: 10.3390/cells8040342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells8040342</ArticleId><ArticleId IdType="pmc">PMC6523091</ArticleId><ArticleId IdType="pubmed">30979017</ArticleId></ArticleIdList></Reference><Reference><Citation>Marshall R, Bellingan G, Laurent G. The acute respiratory distress syndrome: fibrosis in the fast lane. Thorax. 1998;53:815&#x2013;817. doi: 10.1136/thx.53.10.815.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thx.53.10.815</ArticleId><ArticleId IdType="pmc">PMC1745098</ArticleId><ArticleId IdType="pubmed">10193364</ArticleId></ArticleIdList></Reference><Reference><Citation>Leeming DJ, Genovese F, Sand JMB, Rasmussen DGK, Christiansen C, Jenkins G, et al. Can biomarkers of extracellular matrix remodelling and wound healing be used to identify high risk patients infected with SARS-CoV-2?: lessons learned from pulmonary fibrosis. Respir Res. 2021;22:38. doi: 10.1186/s12931-020-01590-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01590-y</ArticleId><ArticleId IdType="pmc">PMC7863042</ArticleId><ArticleId IdType="pubmed">33546680</ArticleId></ArticleIdList></Reference><Reference><Citation>Leng L, Cao R, Ma J, Mou D, Zhu Y, Li W, et al. Pathological features of COVID-19-associated lung injury: a preliminary proteomics report based on clinical samples. Signal Transduct Target Ther. 2020;5:240. doi: 10.1038/s41392-020-00355-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00355-9</ArticleId><ArticleId IdType="pmc">PMC7557250</ArticleId><ArticleId IdType="pubmed">33060566</ArticleId></ArticleIdList></Reference><Reference><Citation>Suresh V, Mohanty V, Avula K, Ghosh A, Singh B, Reddy RK, et al. Quantitative proteomics of hamster lung tissues infected with SARS-CoV-2 reveal host factors having implication in the disease pathogenesis and severity. FASEB J. 2021;35:e21713. doi: 10.1096/fj.202100431R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202100431R</ArticleId><ArticleId IdType="pmc">PMC8206718</ArticleId><ArticleId IdType="pubmed">34105201</ArticleId></ArticleIdList></Reference><Reference><Citation>Biswas S, Thakur V, Kaur P, Khan A, Kulshrestha S, Kumar P. Blood clots in COVID-19 patients: Simplifying the curious mystery. Med Hypotheses. 2021;146:110371. doi: 10.1016/j.mehy.2020.110371.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mehy.2020.110371</ArticleId><ArticleId IdType="pmc">PMC7644431</ArticleId><ArticleId IdType="pubmed">33223324</ArticleId></ArticleIdList></Reference><Reference><Citation>Groff D, Sun A, Ssentongo AE, Ba DM, Parsons N, Poudel GR, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4:e2128568. doi: 10.1001/jamanetworkopen.2021.28568.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2021.28568</ArticleId><ArticleId IdType="pmc">PMC8515212</ArticleId><ArticleId IdType="pubmed">34643720</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarma A, Christenson S, Mick E, Deiss T, DeVoe C, Pisco A, et al. COVID-19 ARDS is characterized by a dysregulated host response that differs from cytokine storm and is modified by dexamethasone. Res Sq. 2021 doi: 10.21203/rs.3.rs-141578/v1.</Citation><ArticleIdList><ArticleId IdType="doi">10.21203/rs.3.rs-141578/v1</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>